654 252 651% (62%) Performance without non-operating items 1 Adjusted EBITDA 282 148 280 (1%) 90% Note: 1 includes gain (loss) from foreign exchange rate, professional fees in relation to M&A activity
: Thousand Baht) Items 30 September 2019 31 December 2018 Increase (Decrease) % Net Assets 6,143,748 6,724,090 (580,342) (8.63) Net Liabilities 2,085,840 2,078,079 7,761 0.37 Shareholders’ equity 4,057,909
Pharma Ltd. took effect as from September 1, 2018). Besides, some expense items decreased by a total of around Baht 14 .5 million in 2019, comprising sales promotion expense, cost of exhibition booth
ratio was of 1. 21:1 time and the Interest bearing debts to total equity ratio was of 0. 98:1 time. The liabilities comprised of major items which follow;- 2.2.1 Account payable and others account payable
, 2018). Besides, some expense items decreased by a total of around Baht 14 .5 million in 2019, comprising sales promotion expense, cost of exhibition booth display, cost of sample products, expense on
last year. Furthermore, the early rainy season has adversely affected the sales of cooling items, and the opening of new stores in the vicinity of existing stores in Bangkok at Rama 9 and Srinakarin has
value that has been revalued to reflect the current market prices of raw materials, which some items were in downtrend and the significant appreciation of Baht, resulting in higher cost of goods sold. The
increased expenses related to the acquisition of SGAH. Apart from these extraordinary items, net profit improvement was also attributed to increased share of profit from associate companies, mainly Hyundai